These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29744832)

  • 1. Nanoparticle Tracking for Protein Aggregation Research.
    Lu X; Murphy RM
    Methods Mol Biol; 2018; 1777():145-158. PubMed ID: 29744832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle Tracking Analysis to Examine the Temperature-Induced Aggregation of Proteins.
    Sladek S; McComiskey K; Healy AM; Tajber L
    Methods Mol Biol; 2019; 2039():131-139. PubMed ID: 31342424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Laser Diffraction for Quantification of Protein Aggregates: Comparison With Resonant Mass Measurement, Nanoparticle Tracking Analysis, Flow Imaging, and Light Obscuration.
    Yoneda S; Niederleitner B; Wiggenhorn M; Koga H; Totoki S; Krayukhina E; Friess W; Uchiyama S
    J Pharm Sci; 2019 Jan; 108(1):755-762. PubMed ID: 30237029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Nanoparticle Tracking Analysis for the Detection of Rod-Shaped Particles and Protein Aggregates.
    Hoover BM; Murphy RM
    J Pharm Sci; 2020 Jan; 109(1):452-463. PubMed ID: 31604086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiamyloidogenic Chemical/Biochemical-Based Designed Nanoparticle as Artificial Chaperone for Efficient Inhibition of Protein Aggregation.
    Pradhan N; Debnath K; Mandal S; Jana NR; Jana NR
    Biomacromolecules; 2018 Jun; 19(6):1721-1731. PubMed ID: 29742346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of prion-like transfer in Huntington's disease models.
    Jansen AH; Batenburg KL; Pecho-Vrieseling E; Reits EA
    Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):793-800. PubMed ID: 28040507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding Amyloid Structures and Disease: A Continuing Challenge in Health Research.
    Chiellini G
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates.
    Filipe V; Hawe A; Jiskoot W
    Pharm Res; 2010 May; 27(5):796-810. PubMed ID: 20204471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Nanoparticle Tracking Analysis for Quantification and Sizing of Submicron Particles of Therapeutic Proteins.
    Zhou C; Krueger AB; Barnard JG; Qi W; Carpenter JF
    J Pharm Sci; 2015 Aug; 104(8):2441-50. PubMed ID: 26017684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multicompany Assessment of Submicron Particle Levels by NTA and RMM in a Wide Range of Late-Phase Clinical and Commercial Biotechnology-Derived Protein Products.
    Hubert M; Yang DT; Kwok SC; Rios A; Das TK; Patel A; Wuchner K; Antochshuk V; Junge F; Bou-Assaf GM; Cao S; Saggu M; Montrond L; Afonina N; Kolhe P; Loladze V; Narhi L
    J Pharm Sci; 2020 Jan; 109(1):830-844. PubMed ID: 31647951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference from Proteins and Surfactants on Particle Size Distributions Measured by Nanoparticle Tracking Analysis (NTA).
    Bai K; Barnett GV; Kar SR; Das TK
    Pharm Res; 2017 Apr; 34(4):800-808. PubMed ID: 28155075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle tracking analysis of particle size and concentration detection in suspensions of polymer and protein samples: Influence of experimental and data evaluation parameters.
    Gross J; Sayle S; Karow AR; Bakowsky U; Garidel P
    Eur J Pharm Biopharm; 2016 Jul; 104():30-41. PubMed ID: 27108267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin-Mediated Acetylation Protects Against Multiple Neurodegenerative Pathologies by Impeding Protein Aggregation.
    Ayyadevara S; Balasubramaniam M; Kakraba S; Alla R; Mehta JL; Shmookler Reis RJ
    Antioxid Redox Signal; 2017 Dec; 27(17):1383-1396. PubMed ID: 28537433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Label-free detection of ApoE4-mediated β-amyloid aggregation on single nanoparticle uncovering Alzheimer's disease.
    Kang MK; Lee J; Nguyen AH; Sim SJ
    Biosens Bioelectron; 2015 Oct; 72():197-204. PubMed ID: 25982728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein aggregation and ER stress.
    Ogen-Shtern N; Ben David T; Lederkremer GZ
    Brain Res; 2016 Oct; 1648(Pt B):658-666. PubMed ID: 27037184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β aggregation with gold nanoparticles on brain lipid bilayer.
    Lee H; Kim Y; Park A; Nam JM
    Small; 2014 May; 10(9):1779-89. PubMed ID: 24664514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles-protein interaction: Role in protein aggregation and clinical implications.
    Parveen R; Shamsi TN; Fatima S
    Int J Biol Macromol; 2017 Jan; 94(Pt A):386-395. PubMed ID: 27746352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteins in aggregates functionally impact multiple neurodegenerative disease models by forming proteasome-blocking complexes.
    Ayyadevara S; Balasubramaniam M; Gao Y; Yu LR; Alla R; Shmookler Reis R
    Aging Cell; 2015 Feb; 14(1):35-48. PubMed ID: 25510159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced fluorescence imaging of in situ protein aggregation.
    Lu M; Kaminski CF; Schierle GSK
    Phys Biol; 2020 Feb; 17(2):021001. PubMed ID: 31914432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical Considerations for Detection and Characterization of Sub-Micron Particles in Protein Solutions by Nanoparticle Tracking Analysis.
    Gruia F; Parupudi A; Polozova A
    PDA J Pharm Sci Technol; 2015; 69(3):427-39. PubMed ID: 26048748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.